BioWorld MedTech

Dec. 4, 2015

MedTech Forum 2015: Brussels disappoints again pushing regulatory reform back 6 months

BRUSSELS – There are some people who are still optimists, believing that the European Union (EU) will make a definitive decision on something sometime soon. Read More

Inside the Beltway: Federal Circuit passes on en banc hearing for Sequenom

Company Eyes Approval in 2017: Stimrelieve receives IDE to launch craniofacial pain treatment device trial

MDT-COV freed up $9.3 billion: Company to reveal cash deployment plans in the 'very near' future

Financings: Nxthera raises $40M in funding round led by Boston Scientific

World in Review: Biontech, Shuwen deliver Mammatyper test in China

Agreements/contracts: Find, Cepheid expand collaboration to help low-income patients

Hit Bits: Two new Veeva cloud products now available

Daily M&A:Novartis could sell contact lens products to help boost Alcon

Briefly Noted

Product briefs

MDD's Diagnostics Extra

Today's news in brief

BioWorld

BioWorld briefs for April 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 14, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Antibodies binding to spike proteins on the surface of SARS-CoV-2 virus

Australian researchers discover new compound to treat long COVID

BioWorld

Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans....

Illustration of human heart with DNA structure background

Early stage cardio data from Verve bump the stock

BioWorld

Positive early stage data for Verve Therapeutics Inc.’s base editing therapy points to a range of development options, including bringing partner Eli Lilly and...